Finanztrends
Deine Einschätzung
Was spricht für und gegen Advanced Proteome Therapeutics in den nächsten Jahren?
Pro
?
L*********** I********** f** d** n******* J****
?
A****************
?
W******* i* V********
Kontra
?
U****************
?
M****
?
M************
Sag uns deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von Advanced Proteome Therapeutics im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
| Larimar Therapeutics Inc. | -2,66 % | -2,82 % | -7,53 % | 9,55 % | 3,61 % | -1,71 % | -62,81 % |
| Northwest Biotherapeutics Inc. | 0,00 % | 36,36 % | 12,50 % | -7,22 % | -12,62 % | -59,64 % | -83,64 % |
| Achieve Life Sciences Inc. | 1,75 % | 4,59 % | 11,76 % | 171,43 % | 54,05 % | 18,75 % | -5,79 % |
News
Spectral AI Q2 Earnings Call Highlights
Key Points
- Interested in Spectral AI, Inc.? Here are five stocks we like better.
- FDA clearance is shifting Spectral AI toward commercialization: The company plans a disciplined U.S. and
NORMA Group Q2 Earnings Call Highlights
Key Points
- Interested in NORMA Group SE? Here are five stocks we like better.
- Profitability improved despite weak automotive demand: Q2 adjusted EBIT rose to EUR 7.6 million from EUR 2.3
ePropelled to Increase Manufacturing Footprint with $60 Million in U.S. Government Funding to Strengthen U.S. Drone Propulsion Supply Chain
Expansion Increases Manufacturing Capacity by 4X and Positions ePropelled as a Leading Domestic Supplier of Advanced Dual-Use Electric Propulsion Systems
COVENTRY, UK / ACCESS Newswire /
